Genmab A/S (CO:GMAB) — Stock Price
Genmab A/S (CO:GMAB) is currently trading at Dkr1992.00 DKK, down 0.35% today. Over the past 52 weeks, shares have ranged between Dkr1384.00 and Dkr2251.00. This page tracks Genmab A/S's live share price on the CO exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Genmab A/S worth.
Genmab A/S (GMAB) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Genmab A/S's daily closing share price and trading volume on the CO exchange over the past year, giving a clear view of recent price momentum and liquidity.
Genmab A/S Income Statement — Revenue, Profit & Earnings by Year
Genmab A/S's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | Dkr21.53 Billion | Dkr16.47 Billion | Dkr14.60 Billion | Dkr8.48 Billion | Dkr10.11 Billion |
| Cost of Revenue | Dkr985.00 Million | Dkr226.00 Million | Dkr0.00 | Dkr0.00 | — |
| Gross Profit | Dkr20.54 Billion | Dkr16.25 Billion | Dkr14.60 Billion | Dkr8.48 Billion | Dkr10.11 Billion |
| Research & Development | Dkr9.75 Billion | Dkr7.63 Billion | Dkr5.56 Billion | Dkr4.18 Billion | Dkr3.14 Billion |
| SG&A | Dkr528.77 Million | Dkr3.30 Billion | Dkr2.68 Billion | Dkr1.28 Billion | Dkr661.00 Million |
| Total Operating Expenses | Dkr13.84 Billion | Dkr10.93 Billion | Dkr8.24 Billion | Dkr5.46 Billion | Dkr3.80 Billion |
| Operating Income | Dkr6.70 Billion | Dkr5.32 Billion | Dkr6.27 Billion | Dkr2.95 Billion | Dkr6.31 Billion |
| EBITDA | Dkr9.70 Billion | Dkr5.99 Billion | Dkr7.33 Billion | Dkr4.18 Billion | Dkr6.16 Billion |
| EBIT | Dkr9.28 Billion | Dkr5.66 Billion | Dkr6.97 Billion | Dkr3.93 Billion | Dkr5.91 Billion |
| Interest Expense | Dkr120.00 Million | Dkr27.00 Million | Dkr21.00 Million | Dkr13.00 Million | Dkr10.00 Million |
| Income Before Tax | Dkr9.16 Billion | Dkr5.64 Billion | Dkr6.95 Billion | Dkr3.98 Billion | Dkr5.90 Billion |
| Income Tax Expense | Dkr1.32 Billion | Dkr1.28 Billion | Dkr1.49 Billion | Dkr975.00 Million | Dkr1.15 Billion |
| Net Income | Dkr7.84 Billion | Dkr4.35 Billion | Dkr5.45 Billion | Dkr2.96 Billion | Dkr4.76 Billion |
Genmab A/S Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Genmab A/S's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | Dkr45.81 Billion | Dkr35.29 Billion | Dkr30.12 Billion | Dkr24.63 Billion | Dkr21.14 Billion |
| Total Current Assets | Dkr27.85 Billion | Dkr33.14 Billion | Dkr28.22 Billion | Dkr22.74 Billion | Dkr18.79 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | Dkr11.24 Billion | Dkr13.27 Billion | Dkr12.43 Billion | Dkr10.38 Billion | Dkr8.82 Billion |
| Net Receivables | Dkr6.59 Billion | Dkr4.95 Billion | Dkr5.89 Billion | Dkr3.40 Billion | Dkr2.71 Billion |
| Inventory | Dkr62.00 Million | Dkr57.00 Million | Dkr-143.00 Million | Dkr-31.00 Million | Dkr-249.00 Million |
| Property, Plant & Equipment | — | — | Dkr1.32 Billion | Dkr975.00 Million | Dkr736.00 Million |
| Goodwill | Dkr2.54 Billion | Dkr0.00 | — | — | — |
| Total Liabilities | Dkr9.11 Billion | Dkr3.68 Billion | Dkr2.84 Billion | Dkr2.43 Billion | Dkr2.02 Billion |
| Total Current Liabilities | Dkr5.31 Billion | Dkr2.48 Billion | Dkr1.82 Billion | Dkr1.57 Billion | Dkr1.25 Billion |
| Long-term Debt | — | — | — | — | — |
| Net Debt | Dkr-8.83 Billion | Dkr-14.10 Billion | Dkr-9.30 Billion | Dkr-8.53 Billion | Dkr-6.94 Billion |
| Total Stockholder Equity | Dkr36.70 Billion | Dkr31.61 Billion | Dkr27.28 Billion | Dkr22.20 Billion | Dkr19.12 Billion |
| Retained Earnings | Dkr23.55 Billion | Dkr19.02 Billion | Dkr14.81 Billion | Dkr10.02 Billion | Dkr7.11 Billion |
Genmab A/S Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Genmab A/S generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | Dkr7.77 Billion | Dkr7.38 Billion | Dkr3.91 Billion | Dkr2.23 Billion | Dkr6.43 Billion |
| Capital Expenditures | Dkr187.00 Million | Dkr376.00 Million | Dkr317.00 Million | Dkr252.00 Million | Dkr307.00 Million |
| Free Cash Flow | Dkr7.58 Billion | Dkr7.00 Billion | Dkr3.60 Billion | Dkr1.98 Billion | Dkr6.13 Billion |
| Investing Cash Flow | Dkr-9.91 Billion | Dkr-1.28 Billion | Dkr-2.76 Billion | Dkr-961.00 Million | Dkr-2.35 Billion |
| Financing Cash Flow | Dkr-3.92 Billion | Dkr-606.00 Million | Dkr-789.00 Million | Dkr-420.00 Million | Dkr71.00 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | Dkr721.00 Million | Dkr586.00 Million | Dkr439.00 Million | Dkr310.00 Million | Dkr200.00 Million |
| Depreciation | Dkr413.00 Million | Dkr327.00 Million | Dkr362.00 Million | Dkr248.00 Million | Dkr259.00 Million |
| Change in Cash | Dkr-5.01 Billion | Dkr4.97 Billion | Dkr936.00 Million | Dkr1.70 Billion | Dkr3.71 Billion |
Genmab A/S Earnings History — EPS Actual vs. Analyst Estimates
Track Genmab A/S's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 06, 2026 | — | — | — |
| Feb 17, 2026 | — | 29.33 | — |
| Nov 06, 2025 | 41.80 | 31.81 | +31.41% |
| Aug 07, 2025 | 34.77 | 25.72 | +35.19% |
| May 08, 2025 | 20.18 | 14.74 | +36.91% |
| Feb 12, 2025 | 60.12 | 24.79 | +142.52% |
| Nov 06, 2024 | 19.81 | 21.56 | -8.12% |
| Aug 08, 2024 | 21.70 | 20.45 | +6.11% |